We need to revive the rights-based agenda and realign research priorities for women's health, says Priya Shetty.

A binding international convention would facilitate a move towards more equitable access to R&D in health, according to Suerie Moon and colleagues.

Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug's use must step up, says Priya Shetty.

Trade deals are threatening generic drugs — we need new ways to incentivise affordable drug development, says health expert Daniele Dionisio.

India urgently needs a permanent dengue surveillance system, say N. Sivagnaname and colleagues.

There is a pressing need for Africa to bolster its pharmaceuticals industry, and that requires the right policy framework, argues Priya Shetty.

Improving health for the poor depends on nurturing local innovations — and learning how to deliver them, argue Abdallah Daar and Peter Singer.

The proposed Sustainable Development Goals need more focus on health to continue the progress achieved with MDGs, argues Priya Shetty.

The revised malaria death toll suggests a need for research into uncertainties in controlling neglected tropical diseases, says Mark Booth.

India's carefully targeted strategy against polio holds lessons for other countries, and for other diseases, argues Priya Shetty.

Encouraging demand for new and increasingly cheap interventions available now can boost health in developing countries, says Charles Kenny.

New clinical trial designs can work for testing both Western and traditional medicines, argue Liang Liu and colleagues.

Countries are using innovative schemes to train and retain health professionals — but they need support, says WHO expert Manuel M. Dayrit.

Neither dispassionate information nor scare stories are the answer: we need public engagement on health interventions, argues Priya Shetty.

Health systems in developing nations aren't ready for the diseases that accompany ageing, writes Priya Shetty.

'Boundary organisations' offer a space away from politics for scientists to engage government officials with their research, says Scott Drimie.

Healthcare policies and research strategies in developing countries must adapt to the new big killers, says Priya Shetty.

Population forecasts may be based on unrealistic assumptions of demographic change in the developing world, warns Carl Haub.

Health scientists in developing countries can use social media to tackle research priorities, argue Alexander E. T. Finlayson and colleagues.

Assessing each country's needs is key to ensuring that medical technologies fulfil their promise, say Sidhartha R. Sinha and Michele Barry.